Year 2018 ACC Guideline Update: The ECDP Report on Non-Statin Therapies for ASHD Reduction in Diabetic Patients—Addressing Statin Intolerance, Poor Target LDL Goal Attainment and Resistance Syndromes in Diabetes Specialty Practice

Year 2018 ACC Guideline Update: The ECDP Report on Non-Statin Therapies for ASHD Reduction in Diabetic Patients—Addressing Statin Intolerance, Poor Target LDL Goal Attainment and Resistance Syndromes in Diabetes Specialty Practice


Published

November 14, 2018

Created by

CMEducation Resources symposium